Elevated activity of antiviral enzyme 2′-5′-oligoadenylate synthetase (OAS) in PBMC from patients with ME/CFS has been observed. This evidence concerns the gene SMOC1 and myalgic encephalomeyelitis/chronic fatigue syndrome.